$CB

Ortega Juan Luis sold (to issuer) 924 shares of CB

Ortega Juan Luis (Executive Vice President*) sold (to issuer) 924 shares of Chubb Ltd (CB) on 2026-05-21.

Original reporting
SEC EDGAR · Ortega Juan Luis
Published May 26, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CB
Neutral
high confidence
Mentioned
$CB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBNeutralLow
01

Why it matters

Because the price and total value are not disclosed and the share count is small, the disclosure is more relevant for monitoring insider activity than for forecasting earnings or guidance changes.

02

Market read

Traders may note insider activity, but there is no fundamental catalyst (earnings/M&A/regulatory action) in the article.

03

What to watch

No price/value disclosed and no 10b5-1 plan indicated; without context on prior trades, directional inference is weak.

Relevance 6/10Timing: Filing dated 2026-05-26 for a trade executed 2026-05-21; any market reaction would be short-lived around disclosure.

Background

SEC Form 4 reports insider transactions; this filing shows an EVP selling shares to the issuer (often associated with buyback participation).

Company-level read

Ticker impact

$CBNeutralHigh confidence
Context

Chubb (CB) disclosed an insider sale to the issuer of 924 shares by EVP Ortega on 2026-05-21, with price not disclosed.

Expected impact

Minimal near-term impact; any move is likely noise around the filing rather than a directional catalyst.

Evidence & confidence

Form 4s are ownership-change disclosures; the transaction is small (924 shares) and explicitly lacks disclosed price/value, with no accompanying company news.

Market effects

No clear sector read-through; this appears company-specific and transaction-structure driven.

None expected beyond potential micro-volatility in CB around the filing.

None expected; no international deal/regulatory element mentioned.

Counterpoint

If the sale were part of a broader pattern (not shown here), it could be interpreted as personal liquidity rather than buyback mechanics.

Key entities

  • Chubb Ltd

    Company subject of the Form 4 insider transaction disclosure.

  • Ortega Juan Luis

    Executive Vice President who sold 924 shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.

$BAXMed

This week in insurance: Catastrophe losses ease, Allianz buys HSBC Life Singapore, Chubb launches shopping cover

A weekly insurance roundup said Asia’s insured natural-catastrophe losses in H1 2026 were under $2.0b, the lowest six-month total since 2017, citing Gallagher Re. It also covered rising transaction-risk claims and new products. Deal news included Allianz buying HSBC Life Singapore for S$2.7b, and Sompo International agreeing to buy Fator Seguradora in Brazil.